Brandes Investment Partners LP Increases Stock Position in Koninklijke Philips (NYSE:PHG)

Brandes Investment Partners LP lifted its holdings in shares of Koninklijke Philips (NYSE:PHG - Free Report) by 4.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 918,635 shares of the technology company's stock after purchasing an additional 43,157 shares during the period. Brandes Investment Partners LP owned about 0.10% of Koninklijke Philips worth $23,260,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in PHG. Wilmington Savings Fund Society FSB purchased a new stake in Koninklijke Philips during the third quarter valued at about $54,000. Farther Finance Advisors LLC boosted its holdings in Koninklijke Philips by 37.1% in the fourth quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company's stock worth $54,000 after acquiring an additional 582 shares in the last quarter. Whipplewood Advisors LLC bought a new stake in Koninklijke Philips during the 4th quarter valued at about $55,000. Allworth Financial LP lifted its position in Koninklijke Philips by 24.9% in the 4th quarter. Allworth Financial LP now owns 3,993 shares of the technology company's stock valued at $105,000 after acquiring an additional 797 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC purchased a new position in shares of Koninklijke Philips during the third quarter valued at approximately $107,000. 13.67% of the stock is owned by hedge funds and other institutional investors.

Koninklijke Philips Price Performance

Shares of Koninklijke Philips stock traded up $0.50 during trading hours on Wednesday, reaching $26.79. The stock had a trading volume of 575,050 shares, compared to its average volume of 871,456. The firm has a market capitalization of $25.18 billion, a PE ratio of -31.89, a PEG ratio of 0.82 and a beta of 0.78. Koninklijke Philips has a twelve month low of $19.10 and a twelve month high of $32.91. The company has a current ratio of 1.23, a quick ratio of 0.74 and a debt-to-equity ratio of 0.59. The stock's 50 day moving average is $26.70 and its 200 day moving average is $27.79.

Remove Ads

Koninklijke Philips (NYSE:PHG - Get Free Report) last released its earnings results on Wednesday, February 19th. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.55 by ($0.01). The business had revenue of $5.38 billion for the quarter, compared to analysts' expectations of $5.10 billion. Koninklijke Philips had a positive return on equity of 10.85% and a negative net margin of 3.88%. Equities analysts expect that Koninklijke Philips will post 1.63 earnings per share for the current fiscal year.

Koninklijke Philips Cuts Dividend

The firm also recently declared an annual dividend, which will be paid on Friday, June 6th. Shareholders of record on Tuesday, May 13th will be paid a dividend of $0.886 per share. The ex-dividend date of this dividend is Tuesday, May 13th. This represents a yield of 2.9%. Koninklijke Philips's dividend payout ratio (DPR) is presently -89.29%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on PHG shares. StockNews.com upgraded Koninklijke Philips from a "hold" rating to a "buy" rating in a research note on Saturday, March 8th. BNP Paribas raised shares of Koninklijke Philips from a "neutral" rating to an "outperform" rating in a research note on Tuesday, February 25th. Finally, UBS Group upgraded Koninklijke Philips from a "neutral" rating to a "buy" rating in a report on Thursday, February 20th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, Koninklijke Philips currently has an average rating of "Moderate Buy".

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.